Peanut cysteine-rich peptide, coding gene, bacteriostatic agent and application

By extracting and chemically synthesizing cysteine-rich peptides from peanuts, the environmental pollution and resistance of chemical fungicides in agriculture are solved, effective inhibition of a variety of agricultural pathogens is achieved, and environmental protection is provided. , efficient antibacterial measures.

CN118994346AActive Publication Date: 2024-11-22GUANGZHOU SGY AGRI SCI & TECH CO LTD

Patent Information

Application Number
CN202411350080.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-26
Publication Date
2024-11-22
Estimated Expiration
2044-09-26

AI Technical Summary

Technical Problem

Existing chemical fungicides have problems with environmental pollution, drug residues and pathogen resistance in agricultural disease prevention and control, and it is difficult to effectively prevent and control a variety of fungal diseases, especially the protection effect of wheat, rice, potatoes and other crops is limited.

Method used

A novel cysteine-rich peptide extracted from peanuts and prepared by solid-phase chemical synthesis method, with broad-spectrum antibacterial activity, is effective against a variety of agricultural pathogenic bacteria, including wheat leaf blight, tomato blight, etc. Suppress pathogen growth through a unique helical structure.

Benefits of technology

This cysteine-rich peptide can significantly inhibit the growth of a variety of agricultural pathogenic bacteria, reduce the use of chemical pesticides, reduce the risk of environmental pollution, avoid drug resistance problems, maintain long-term prevention and control effects, and is suitable for aquaculture and crop protection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118994346A_ABST
    Figure CN118994346A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of bioengineering, in particular to preparation and application of peanut antibacterial peptide. A novel antibacterial peptide family member is identified and extracted from a peanut transcriptome library for the first time, and the novel antibacterial peptide family member is named as a peanut cysteine-rich peptide. The cysteine-rich peptide prepared by using a solid-phase chemical synthesis method shows broad-spectrum antibacterial activity, and the polypeptide fragment of the cysteine-rich peptide shows strong inhibiting and killing capability on various common pathogenic bacteria and crop mould.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of bioengineering, and particularly relates to a peanut cysteine-rich peptide and application thereof. Background Art

[0002] There are many fungal pathogens in nature that affect the growth and yield of many crops, such as wheat leaf blight (Alternaria triticina) and tomato wilt (Fusarium oxysporum f.sp. lycopersici). Other important pathogens include rice sheath blight (Rhizoctonia solani) and potato wilt (Sclerotium rolfsii). If these pathogens are not managed, they can cause serious crop losses, highlighting the importance of understanding and mitigating these pathogens.

[0003] Several widely grown crops such as wheat, rice, and potato are threatened by these fungal pathogens. For example, Pythium aphanidermatum and Sclerotinias clerotiorum cause damping-off and head rot in tomato and sunflower, respectively. Alternaria solani and Alternaria alternate f.sp. lycopersici both cause early blight in tomato and potato. Ceratocystis paradoxa causes pineapple disease in sugarcane, while Phytophthora infestans is notorious for causing late blight in potato. The diversity of pathogens and affected crops highlights the critical need to research and develop effective disease management strategies.

[0004] These fungal pathogens not only reduce crop yields, but also reduce crop quality and may even lead to the destruction of entire crops. For example, wheat leaf blight (Alternaria triticina) forms lesions on leaves, which seriously affect photosynthesis and ultimately lead to reduced yields. Tomato wilt (Fusarium oxysporum f.sp. lycopersici) infects plants through the roots, causing the plants to wilt and die. Sheath blight (Rhizoctonia solani) can cause disease throughout the growth period of rice, especially in hot and humid environments, which can easily cause large-scale yield losses. Potato wilt (Sclerotium rolfsii) forms a large number of sclerotia, and the disease spreads rapidly and is difficult to control.

[0005] To deal with these fungal diseases, agricultural scientists and farmers need to adopt integrated disease management strategies, including the use of disease-resistant varieties, optimized planting methods and the rational use of chemical agents. Prevention and control measures for sudden wilt (Pythium aphanidermatum) and sunflower head rot (Sclerotiniasclerotiorum) include soil disinfection and crop rotation. The management of early blight (Alternaria solani) and tomato early blight (Alternaria alternate f.sp. lycopersici) requires timely spraying of fungicides in the early stages of the disease. Pineapple pathogen (Ceratocystis paradoxa) and late blight (Phytophthora infestans) require strengthened disease monitoring and prevention, and timely measures should be taken to control the spread of the disease. Continuous research and innovation are essential for the development of new disease-resistant varieties and environmentally friendly prevention and control measures to ensure the sustainable development of agricultural production.

[0006] In order to reduce chemical pollution and antibiotic resistance, green management methods are becoming increasingly important in agricultural disease control. Currently, widely used chemical fungicides not only pollute the environment, but may also cause pesticide residue problems and affect food safety. At the same time, long-term use of antibiotics and chemical agents will cause pathogen resistance problems, making disease control more difficult. To solve these problems, scientists and farmers are exploring more environmentally friendly and efficient alternatives, among which peanut antimicrobial peptides have become the focus of attention.

[0007] Peanut (Arachis hypogaea) is a leguminous plant widely distributed in Guangxi, Hainan and other places. It is an important economic crop in the southern coastal areas. Peanut is not only an important food and oil crop, but also rich in protein, fat, vitamins and minerals, with high nutritional value. Antimicrobial peptides (AMPs) are an important part of the innate immune system and have broad-spectrum antimicrobial activity. Common secondary structures include α helix, β fold and β hairpin. In recent years, with the rapid development of aquaculture, water pollution and the outbreak of pathogenic organisms have become major bottlenecks. Traditional antibiotics and chemical drug control methods have led to serious problems of drug residues and drug resistance. As a new type of biosafe antibiotic, peanut antimicrobial peptides have good thermal stability and water solubility, are not easy to develop drug resistance, can not only replace traditional antibiotics to inhibit and kill pathogenic organisms, but also enhance the immunity of farmed animals and improve production efficiency, and have great application prospects in aquaculture.

[0008] Peanut antimicrobial peptide is a naturally occurring antimicrobial substance with broad-spectrum antimicrobial activity, effective against a variety of fungal pathogens. Unlike traditional chemical agents, peanut antimicrobial peptide is environmentally friendly, harmless to humans, and has no drug resistance problem, making it an ideal alternative to chemical agents, which can effectively prevent and control diseases while reducing negative environmental impacts.

[0009] The use of peanut antimicrobial peptides for disease control can effectively reduce the use of chemical pesticides and reduce the risk of environmental pollution. Traditional chemical agents are prone to pollute the soil, water sources and air during application, affecting the health of the ecosystem. As a natural substance, peanut antimicrobial peptides can be quickly degraded by the environment after application and will not remain in the soil and water sources, thereby reducing harm to the environment. In addition, peanut antimicrobial peptides are harmless to human health and will not cause allergies or other adverse reactions, which is crucial to ensuring the safety of agricultural products and the health of consumers. Another important advantage is that peanut antimicrobial peptides have no drug resistance problem. Long-term use of chemical agents and antibiotics can cause pathogens to develop drug resistance, making these agents less effective or even ineffective. Peanut antimicrobial peptides inhibit the growth of pathogens through a unique mechanism, and it is difficult for pathogens to develop drug resistance. Therefore, peanut antimicrobial peptides can maintain a high degree of control in long-term use, which is of great significance for the continuous control of agricultural diseases.

[0010] In order to promote the application of peanut antimicrobial peptides, scientists are constantly researching and optimizing their production and application technologies. Through genetic engineering and biotechnology, high-purity peanut antimicrobial peptides can be produced on a large scale, and formulas suitable for different crops and diseases can be developed. Scientists are also exploring the synergy between peanut antimicrobial peptides and other biological control measures to improve their control effects. For example, combining peanut antimicrobial peptides with beneficial microorganisms can form a more comprehensive disease control system and enhance crop disease resistance. The promotion and application of green management measures such as peanut antimicrobial peptides will help reduce the use of chemical agents, reduce the risk of environmental pollution, and improve the quality of agricultural products.

[0011] In the present invention, we obtained a novel antimicrobial peptide family member from the peanut transcriptome library for the first time, named peanut cysteine-rich peptide. The cysteine-rich peptide was prepared by solid phase chemical synthesis, and the antimicrobial peptide has a polypeptide fragment with broad-spectrum antimicrobial activity. The polypeptide fragment has strong inhibitory and killing activity against a variety of agricultural pathogens, including wheat leaf blight pathogen (Alternaria triticina), tomato wilt pathogen (Fusarium oxysporum f.sp. lycopersici), sheath blight pathogen (Rhizoctonia solani), potato wilt pathogen (Sclerotium rolfsii), sudden wilt pathogen (Pythium aphanidermatum), sunflower head rot pathogen (Sclerotiniasclerotiorum), early blight pathogen (Alternaria solani), tomato early blight pathogen (Alternaria alternate f.sp. lycopersici), pineapple pathogen (Ceratocystis paradoxa) and late blight pathogen (Phytophthorainfestans). Summary of the invention

[0012] In order to achieve the above object, the technical solution adopted by the present invention is:

[0013] The present invention provides a peanut cysteine-rich peptide, the nucleotide sequence of the antimicrobial peptide is shown in SEQ ID NO.1; specifically:

[0014] GATAATGCCATCAACTTTATCAAAACTGGGCAGTGCCTTGGTAAATGT

[0015] GCAGACGACATTGTTTGCTGCGGGATGAAAGATTGCTACATTAATTAC

[0016] ATGCAGCACTTCTTGCCTTGTGCGGTGAAATGTGAAAACTTGGGGTTC

[0017] CTGTGCATCCCATCATGCAGGGATATCGAGAATCCTCTTACTAATGCTT

[0018] TGACAGGGTTATCCTCTCACAAGGTAGGACCATCTCACAAGGTAAAACCGGGTCACCGGGTACCGCCATCTCACCGGCCA.

[0019] The amino acid sequence is shown in SEQ ID NO.2; specifically:

[0020] DNAINFIKTGQCLGKCADDIVCCGMKDCYINYMQHFLPCAVKCENLGFL CIPSCRDIENPLTNALTGLSSHKVGPSHKVKPGHRVPPSHRP.

[0021] Another object of the present invention is to provide a peanut cysteine-rich peptide, which is a polypeptide fragment selected from cysteine-rich peptides with antibacterial activity. The three-dimensional structure of this peptide sequence shows several key structures of complex proteins ( Figure 1 ). Peanut cysteine-rich peptides are characterized by a unique helical structure. This peptide is composed of multiple helical coils, mainly in blue and yellow, indicating different types of secondary structures or functional regions. The red part in the image may be located at one end of the peptide, indicating a specific functional group or active site, which may indicate the N-terminus or a specific biochemically active region. This structural representation is helpful for visualizing the potential interactions of the molecule with other biomolecules or for studying its properties in a biochemical environment.

[0022] A polypeptide or protein containing the above antimicrobial peptide is also within the protection scope of the present invention.

[0023] The cysteine-rich peptide prepared by the solid phase chemical synthesis method of the present invention exhibits broad-spectrum antibacterial activity, and its polypeptide fragments show strong inhibitory and killing capabilities against a variety of common pathogenic bacteria and crop molds.

[0024] The present invention has the following beneficial effects:

[0025] The present invention provides for the first time a member of the cysteine-rich peptide family with broad-spectrum antibacterial activity derived from peanuts. The active fragment of the antibacterial peptide can be prepared in large quantities through solid-phase chemical synthesis, and the active fragment of the antibacterial peptide has a strong inhibitory and killing effect on common pathogenic Vibrio and foodborne pathogenic Vibrio in the aquaculture industry. It can be used as an ecologically safe antibacterial additive in aquaculture and has broad application prospects. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 This is the tertiary protein structure diagram of the mature peptide of peanut cysteine-rich peptide;

[0027] Figure 2 HPLC and mass spectrometry identification of cysteine-rich peptides and reference peptides; A, HPLC of cysteine-rich peptides; B, HPLC of reference peptides; C, mass spectrometry of cysteine-rich peptides; D, mass spectrometry of reference peptides;

[0028] Figure 3Time curve of the inhibitory rate of peanut cysteine-rich peptide and control peptide on the growth of wheat leaf blight pathogen (Alternariatriticina);

[0029] Figure 4 Time curve of the inhibition rate of peanut cysteine-rich peptide and control peptide on the growth of tomato wilt pathogen (Fusariumoxysporumf.sp.lycopersici);

[0030] Figure 5 Time curve of the inhibitory rate of peanut cysteine-rich peptide and control peptide on the growth of Rhizoctonia solani;

[0031] Figure 6 Antimicrobial peptide hemolysis experiment; A, peanut cysteine-rich peptide hemolysis experiment; B, control peptide hemolysis experiment. DETAILED DESCRIPTION

[0032] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, the specific embodiments of the present invention are described in detail below in conjunction with the accompanying drawings. In the following description, many specific details are set forth to facilitate a full understanding of the present invention. However, the present invention can be implemented in many other ways different from those described herein, and those skilled in the art can make similar improvements without violating the connotation of the present invention, so the present invention is not limited by the specific implementation disclosed below.

[0033] Example 1: Acquisition of peanut cysteine-rich peptide gene sequence

[0034] Peanut meal products were purchased from Zhengzhou Huaguan Biotechnology Development Co., Ltd. Its physical and chemical indicators are as follows (mass content):

[0035] - crude protein content: ≥46%, - crude fat content: ≤2%, - crude ash content: ≤8%, - crude fiber content: ≤10% and - moisture content: ≤12%.

[0036] Extraction of total RNA: Take 1 gram of peanut meal and make sure the sample is clean and free of contamination. Place the peanut meal in a test tube containing TRIzol reagent (total RNA extraction reagent, Life Technologies, USA) and let it stand at room temperature for 5 minutes with 1 mL of TRIzol reagent. Then, add 200 μL of chloroform, shake vigorously for 15 seconds and let it stand for 10 minutes. Centrifuge at 12,000xg for 15 minutes and separate the supernatant. Transfer the supernatant to a new test tube, add 500 μL of isopropanol, mix well and let it stand for 10 minutes. Centrifuge at 12,000xg for another 10 minutes, discard the supernatant and keep the precipitate (RNA). Wash the RNA precipitate twice with 1 mL of 75% ethanol, centrifuge at 7,500xg for 5 minutes each time, discard the supernatant and dry the precipitate. The RNA precipitate was dissolved in 30 μL RNase-Free water (DEPC water (RNase-free water)), and its concentration and purity were determined using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, USA). A260 = 1.8, A280 = 1.0, and concentration = 180 ng / μL. The A260 / A280 ratio of the sample was between 1.8 and 2.0, indicating that the RNA purity was good and there was no obvious protein or other contaminants.

[0037] Quality control and transcriptome library sequencing:

[0038] RNA integrity assessment

[0039] First, RNA integrity was assessed using the Agilent 2100 Bioanalyzer (Agilent Technologies, USA). Ensuring that the RNA integrity (RIN value) of the sample is greater than 7.0 is a prerequisite for high-quality transcriptome sequencing. In this experiment, the RIN value of the RNA sample we extracted was 8.2, indicating that the RNA quality was good and the integrity was high, which was suitable for subsequent library construction and sequencing.

[0040] Library construction

[0041] The library was constructed using the NEBNext Ultra RNA Library Prep Kit for Illumina (New England Biolabs, USA) and was operated strictly in accordance with the instructions of the kit. The specific steps are as follows: First, the total RNA sample was fragmented by ultrasonic treatment to obtain RNA fragments of about 200-300 bp in length to generate evenly distributed fragments to ensure the smooth progress of the subsequent reverse transcription and amplification process. Then, the fragmented RNA was reverse transcribed using random primers to generate the first-strand cDNA to cover the entire transcriptome and ensure representativeness. Next, the cDNA was end-repaired and an A tail was added to the 3' end to connect the adapter, thereby ensuring the consistency of the ends of all cDNA fragments and promoting the efficient connection of the adapter. Subsequently, the adapters containing sequencing primer sequences were connected, which contained the primer sequences required by the Illumina sequencing platform to prepare for subsequent sequencing. Next, random primers were used for PCR amplification to obtain the final cDNA library to ensure sufficient library volume to meet the needs of high-throughput sequencing. Finally, the Agilent 2100 Bioanalyzer was used again to detect the quality of the library to ensure that the fragment length and concentration were appropriate. The target fragment length is between 200-300bp, and the concentration is 28nM. The specific test results show that the library fragment length is between 200-300bp, and the concentration is 28nM, which meets the standards of high-quality sequencing libraries.

[0042] High-throughput sequencing

[0043] High-throughput sequencing was performed using the Illumina NovaSeq 6000 platform, using a double-end 150bp (PE150) sequencing mode. The specific steps are as follows: Load the library sample onto the Illumina NovaSeq 6000 sequencing platform, and each sample is labeled with a different barcode to ensure sample identification during mixed sequencing of multiple samples. Start the sequencer and perform double-end 150bp sequencing. By reading the sequences at both ends of the DNA fragment, sequencing errors are reduced, and sequencing accuracy and data coverage are improved. After sequencing, raw data (raw reads) are collected. In this experiment, the sequencing depth of the sample reached 35 million reads, ensuring data coverage and accuracy. Preliminary data processing uses Illumina official software, including removing low-quality reads and adapter sequences, and the processed data is used for subsequent bioinformatics analysis. The above results show that each step of the sample from RNA extraction, library construction to high-throughput sequencing is strictly in accordance with standard operations, ensuring the high quality and reliability of the data. Specific data examples are as follows: the RNA integrity assessment RIN value is 8.2, the library quality detection fragment length is 200-300bp, the concentration is 28nM, and the sequencing depth of high-throughput sequencing is 35 million reads.

[0044] Transcript assembly: FastQC: FastQC is an open source tool widely used to assess the quality of high-throughput sequencing data. It comes from Babraham Bioinformatics, UK and can be legally downloaded and used from its official website. Trinity: Trinity is an open source software for de novo transcript assembly provided by the Broad Institute. The software is available on its official GitHub page and is free. BUSCO: BUSCO (Benchmarking Universal Single-Copy Orthologs) is a tool for evaluating assembly and annotation of genomes. A free version is available for academic purposes. It can be obtained from its official website or GitHub page. blastp: BLAST is an open source tool suite provided by the National Center for Biotechnology Information (NCBI) of the United States. It can be legally downloaded and used for free.

[0045] FastQC (Babraham Bioinformatics, UK) was used to perform quality control on the raw data and remove low-quality reads and adapter sequences. Trinity software (v2.8.5, Broad Institute, USA) was used to perform denovo assembly of transcripts. The memory parameters were set to 50GB and the number of processing threads was set to 16. Finally, BUSCO (Benchmarking Universal Single-Copy Orthologs) was used to evaluate the integrity of the assembly. Finally, blastp software was used to screen a peanut antimicrobial peptide DNA sequence SEQ ID NO.1 for the first time by homology alignment. Its gene sequence is as follows:

[0046] GATAATGCCATCAACTTTATCAAAACTGGGCAGTGCCTTGGTAAATGT

[0047] GCAGACGACATTGTTTGCTGCGGGATGAAAGATTGCTACATTAATTAC

[0048] ATGCAGCACTTCTTGCCTTGTGCGGTGAAATGTGAAAACTTGGGGTTC

[0049] CTGTGCATCCCATCATGCAGGGATATCGAGAATCCTCTTACTAATGCTT

[0050] TGACAGGGTTATCCTTCCACAAGGTAGGACCATCTCACAAGGTAAAA

[0051] CCGGGTCACCGGGTACCGCCATCTCACCGGCCA

[0052] (a) Sequence characteristics:

[0053] Length: 273

[0054] ●Type: Nucleotide sequence

[0055] ●Chain type: Single chain

[0056] ●Topology: Linear

[0057] (b) Molecular type: Nucleotide

[0058] (c) Assumption: No

[0059] (d) Antonym: No

[0060] (e) Original source: Peanut

[0061] The full-length amino acid sequence of peanut cysteine-rich peptide is SEQ ID NO.2, which is as follows: DNAINFIKTGQCLGKCADDIVCCGMKDCYINYMQHFLPCAVKCENLGFL CIPSCRDIENPLTNALTGLSSHKVGPSHKVKPGHRVPPSHRP

[0062] (a) Sequence characteristics:

[0063] Length: 91

[0064] ●Type: amino acid sequence

[0065] ●Chain type: Single chain

[0066] ●Topology: Linear

[0067] (b) Molecule type: protein

[0068] (c) Assumption: No

[0069] (d) Antonym: No

[0070] (e) Original source: Peanut

[0071] The peptide structure was analyzed by online Alphafold2, and the peptide chain structure mainly showed an alpha helix, which is a common secondary structure in proteins and peptide chains. The right-handed helical structure is stabilized by hydrogen bond interactions between the main chain amide and carbonyl groups. The alpha helix is ​​tightly wound, and the side chains of the amino acids protrude outward. Different colors are used in the image, which may be used to distinguish specific regions or residues in the helix, showing an ordered conformation without obvious disordered regions or beta folded structures. This alpha helical structure usually plays a key role in the stability and function of proteins.

[0072] Example 2: Identification of Peanut Cysteine-Rich Peptides and Control Peptides

[0073] The control peptide GenBank No. XM_021104843.1 has a 78% homology with the current peanut cysteine-rich peptide amino acid sequence. Peanut cysteine-rich peptide and control peptide (Genbank No. XP_020960502.1) were commissioned to be synthesized by Changzhou Kanglong Biotechnology Co., Ltd. This HPLC analysis of the synthesized sample peanut cysteine-rich peptide and control peptide. The chromatographic column used was Gemini-NX 5μC18110A (model 00B-4454-B0), with a size of 4.6*250mm (inner diameter*length). Mobile phase A was an acetonitrile solution with a final volume concentration of 0.1% trifluoroacetic acid, and mobile phase B was an aqueous solution with a final volume concentration of 0.1% trifluoroacetic acid. The gradient elution program (v / v) was as follows: at the beginning (0.0 min), phase A accounted for 10% by volume, and phase B accounted for 90%; at 25.0 min, the volume content of phase A reached 100% in a linear gradient, and phase B was 0%; from 25.0 min, phase A was maintained at 100%, and phase B was 0% until 30.0 min. The injection volume was 20 μl, the detection wavelength was 220 nm, and the flow rate was 1.0 ml / min.

[0074] During the analysis, the sample was first injected into the HPLC system at a volume of 20 μL. The detection used a Gemini-NX5μC18110A column, the detection wavelength was set to 220 nm, and the flow rate of the mobile phase was 1.0 mL / min. This configuration ensures that the target compounds in the sample are fully separated and detected in the high performance liquid chromatography system. Mobile phase A is a solution of trifluoroacetic acid in acetonitrile with a final volume concentration of 0.1%, and mobile phase B is a solution of trifluoroacetic acid in water with a final volume concentration of 0.1%. Separation was performed using the following gradient elution program: starting from 0.0 minutes, phase A was 10% and phase B was 90%; at 25.0 minutes, phase A gradually increased to 100%, and phase B decreased to 0%; this ratio was maintained (phase A 100%, phase B 0%)

[0075] The mobile phase was stopped at 30.0 minutes. The flow rate was set to 1.0 ml / min. This method effectively separated and detected the target compounds in the sample. The results showed that the main peak of peanut cysteine-rich peptide appeared at 15.4 minutes, indicating that the purity of this component was high ( Figure 2 A). From the chromatogram provided, it can be seen that the main peaks of the synthetic peanut cysteine-rich peptide and the control peptide appear at about 15.4 minutes ( Figure 2 A) and 17.2 minutes ( Figure 2 B). This peak is the most prominent and probably represents the peanut cysteine-rich peptides and the control peptide. To determine purity, the area of ​​this major peak needs to be compared to the total area of ​​all peaks. The formula for calculating the percentage of purity is: the area of ​​the major peak divided by the total area of ​​all peaks, multiplied by 100. From the chromatogram, the major peak is much larger than any other peak, which indicates that the sample is very pure. If the minor peaks are very small compared to the major peak, it is reasonable to assume that the purity is over 90%. Based on visual estimation, this sample is indeed over 95% pure.

[0076] Mass Spectrometry Report

[0077] The samples were peanut cysteine-rich peptide and control peptide

[0078] Instrument: SHIMADZU LCMS-2020

[0079] Probe type: ESI

[0080] Probe bias: +4.5kV

[0081] Sample lot number: P240422-WY181666

[0082] Molecular weight: peanut cysteine-rich peptide 9968.63Da, control peptide 12986.33Da

[0083] Experimental process and detailed parameters

[0084] In this mass spectrometry analysis, peanut cysteine-rich peptides and control peptides were used, and the analysis date was May 27, 2024. The mass spectrometer used was SHIMADZU LCMS-2020, the probe type was electrospray ionization (ESI), and the probe bias was set to +4.5kV.

[0085] Sample preparation and testing conditions

[0086] 1. Sample Preparation

[0087] The sample concentration was 1 mg / mL and was dissolved in a solution of 50% water and 50% acetonitrile by volume. The prepared sample was injected into the mass spectrometer at a flow rate of 0.2 mL / min.

[0088] 2. Instrument Settings

[0089] -Atomizing gas flow rate: 1.5L / min (protective gas is nitrogen)

[0090] -Detector voltage: 1.2kV

[0091] -CDL voltage: -20.0V

[0092] -CDL temperature: 250℃

[0093] -Heating module temperature: 400℃

[0094] -Mobile phase composition: 50% water and 50% acetonitrile (V / V)

[0095] Detailed experimental steps

[0096] 1. Sample injection

[0097] The prepared samples were injected into the mass spectrometry system with a flow rate set at 0.2 mL / min to ensure stable injection and uniform distribution of the samples.

[0098] 2. Electrospray ionization (ESI) process

[0099] The sample was ionized by the ESI probe, and the probe bias was set to +4.5 kV to generate charged droplets. The nebulizer gas flow rate was set to 1.5 L / min, using the positive ion mode to help nebulize the sample and improve ionization efficiency.

[0100] 3. Ion transmission and detection

[0101] The ionized sample ions passed through the neutral dissociation zone (CDL), and the CDL voltage was set to -20.0 V and the CDL temperature was set to 250 ° C to effectively transmit and cool the ions. The detector voltage was set to 1.2 kV to detect and amplify the ion signal.

[0102] 4. Data Recording and Analysis

[0103] During mass spectrometry analysis, the mass-to-charge ratio (m / z) and intensity signal of the sample are recorded to ensure the accuracy and reliability of the analysis results. The experimental running time is set according to the properties of the sample and the analysis requirements, usually from several minutes to more than ten minutes.

[0104] Experimental Results

[0105] By mass spectrometry analysis, peanut cysteine-rich peptide 9968.27 ( Figure 2 C), control peptide 12986.25 ( Figure 2D), the experimental data records the mass-to-charge ratio (m / z) and corresponding signal intensity of each component in detail, helping analysts to accurately identify and quantify each component in the sample. These detailed data and parameters ensure the repeatability and reliability of mass spectrometry experiments, and ensure the accuracy and credibility of the analysis results.

[0106] Example 3: Analysis of the minimum inhibitory concentration (MIC) and growth inhibition time curve of peanut cysteine-rich peptide and control peptide (GenBank No. XP_015936675.1) against wheat leaf blight pathogen (Alternaria triticina)

[0107] The MIC values ​​of antimicrobial peptides were determined using the microdilution method [Saporito P., Mojsoska B., Olesen AL, Jenssen H. Antibacterial mechanisms of GN-2 derived peptides and peptoids against Escherichia coli. Biopolymers. 2019; 110: e23275; Cui H., Zhang C., Li C., Lin L. Antimicrobial mechanism of clove oil on Listeria monocytogenes. Food Control.]. First, under sterile conditions, 10 mg of mycelium of wheat leaf blight pathogen was weighed and inoculated into 50 ml of YPD liquid culture medium (Zeye Biotechnology, ZY130895, the same below), and the culture medium was transferred to a 250 ml conical flask to provide sufficient ventilation. The conical flask was cultured in a constant temperature shaker at 28 ° C, and the shaking speed was set to 200 revolutions per minute (rpm). The culture time was 48 hours, during which the OD600 value was sampled regularly to ensure that the spore concentration was within the required range (OD600≈0.5-1), and the indicator bacterial solution was obtained and added to a 96-well titration plate, 100 microliters per well. Then, a serial dilution of equal volume of peptide solution was performed (100 microliters of peptide aqueous solution per well), and the specific peptide concentrations in the wells after dilution were: 0μM, 2μM, 4μM, 6μM, 8μM, 10μM, 12μM, 14μM, 16μM, 18μM and 20μM, and incubated at 28°C for 48 hours. The lowest antimicrobial peptide concentration without visible microbial growth under the minimum inhibitory concentration (MIC) condition was determined using the ELISA (SPARK) method. The concentration of the purified antimicrobial peptide was adjusted to the MIC level with water for time-kill analysis, and the same volume of peptide aqueous solution as the indicator bacterial solution (obtained as above) was applied to a 96-well plate (at least three wells for each concentration). The plates were then incubated at 28° C. for 2, 4, 6, 8, 10, 12 and 24 hours, after which the OD values ​​were measured at 600 nm.

[0108] The inhibition test of peanut cysteine-rich peptide and control peptide was modified according to the previously described method [Guangming S., Yang Y., Yuan Q., Shi G., Wu L., Lou Z., Huo R., Wu H., Borriss R., Gao X. Bacillomycin D Produced by Bacillus amyloliquefaciens Is Involved in the Antagonistic Interaction with the Plant-Pathogenic Fungus Fusarium graminearum. Appl. Environ. Microbiol. 2017; 83: e01075–e01117.]. 200 μL (1 mg / mL) of antimicrobial peptide was evenly mixed with 10 mL of spores of Psoralea corylifolia (10 7 / mL) and cultured at 28°C. Observe and record the spore number inhibition rate every 2 hours ( Figure 3 ). To calculate the spore number inhibition rate every 2 hours, first record the spore number of the control group (200 μL water and 10 ml of wheat leaf blight spores are evenly mixed) and the treatment group (200 μL (1 mg / mL) antimicrobial peptide and 10 ml of wheat leaf blight spores are evenly mixed). The control group is the spore number that has not been treated with inhibition (200 μL water and 10 ml of wheat leaf blight spores are evenly mixed and cultured at 28°C. Observe and record the spore number inhibition rate every 2 hours), and the treatment group is the spore number that has been treated with inhibition (200 μL (1 mg / mL) antimicrobial peptide and 10 ml of wheat leaf blight spores are evenly mixed (10 7 / mL) and cultured at 28°C. The spore number inhibition rate was observed and recorded every 2 hours from 0 to 10 hours.

[0109] The calculation formula of inhibition rate is:

[0110]

[0111] Among them, N control represents the number of spores in the control group, N treatment Represents the number of spores in the treatment group. Through this formula, the percentage reduction in the number of spores in the treatment group relative to the control group, i.e., the inhibition rate, can be calculated.

[0112] The specific operation steps are as follows: 1. Record the number of spores in the control group and the treatment group every 2 hours. 2. Use the above formula to calculate and obtain the inhibition rate at each recording time.

[0113] For example, if the spore count in the control group is 200 and the spore count in the treated group is 150 at a certain time point, the inhibition rate is calculated as:

[0114]

[0115] This means that at this time point, the number of spores in the treated group was reduced by 25 relative to the control group.

[0116] The experimental results showed that the MICs against wheat leaf blight pathogen were 9.5 μM peanut cysteine-rich peptide and 13.7 μM control peptide.

[0117] To prepare the spore inoculum of wheat leaf blight pathogen, the experimental operation was carried out according to the following steps: First, under sterile conditions, 1 mg of the strain (wheat leaf blight pathogen) was weighed and inoculated into 50 ml of YPD liquid medium (OD600≈0.02-0.05). The culture medium was transferred to a 250 ml Erlenmeyer flask to provide sufficient ventilation. The Erlenmeyer flask was cultured in a constant temperature shaker at 25°C, and the shaking speed was set to 200 revolutions per minute (rpm). The culture time was 48 hours, during which samples were taken regularly to measure the OD600 value to ensure that the spore concentration was within the required range. After the culture was completed, the culture solution was filtered using sterile gauze or filter paper, the spore suspension was collected and stored in an appropriate preservation solution for subsequent use.

[0118] Figure 3 The antibacterial time curves of peanut cysteine-rich peptides and control peptides on the growth of wheat leaf blight pathogen (Alternariatriticina) are shown. According to the data in the figure, peanut cysteine-rich peptides and control peptides showed significant inhibitory effects on the growth of wheat leaf blight pathogen (Alternariatriticina) at different time points. As time went on, the antibacterial effect gradually increased, especially after 4 hours. The specific analysis results are as follows: 1. Early inhibitory effect: Within 2 hours, the antibacterial effect was relatively weak, but a certain growth inhibition effect could still be observed. Mid-term inhibitory effect: After 4 hours, the antibacterial effect was significantly enhanced, showing that peanut cysteine-rich peptides had a strong inhibitory effect on pathogens. Long-term inhibitory effect: At 10 hours, the antibacterial effect reached its highest point, showing that peanut cysteine-rich peptides and control peptides have long-lasting and effective antibacterial activity. The antibacterial effect of peanut cysteine-rich peptides is higher than that of the control peptide ( Figure 3 ).

[0119] In general, peanut cysteine-rich peptides and control peptides have a significant inhibitory effect on the growth of wheat leaf blight pathogens, and the inhibitory effect becomes more obvious as time goes by. This suggests that peanut cysteine-rich peptides may have potential application value in plant disease resistance.

[0120] Example 4: Analysis of the Minimum Inhibitory Concentration (MIC) and Growth Inhibition Rate of Peanut Cysteine-Rich Peptide and Control Peptide (GenBank No. XP_015936675.1) against Fusarium oxysporum f.sp. lycopersici

[0121] The MIC values ​​of antimicrobial peptides were determined using the microdilution method [Saporito P., Mojsoska B., Olesen AL, Jenssen H. Antibacterial mechanisms of GN-2 derived peptides and peptoids against Escherichia coli. Biopolymers. 2019; 110: e23275; Cui H., Zhang C., Li C., Lin L. Antimicrobial mechanism of clove oil on Listeria monocytogenes. Food Control.]. First, under sterile conditions, 10 mg of tomato wilt fungus (Fusarium oxysporum f.sp.lycopersici) mycelium was weighed and inoculated into 50 ml of YPD liquid culture medium, and the culture medium was transferred to a 250 ml Erlenmeyer flask to provide sufficient ventilation. The flask was placed in a constant temperature shaker at 28°C and the shaking speed was set to 200 revolutions per minute (rpm). The culture time was 48 hours, during which the OD600 value was regularly sampled to ensure that the spore concentration was within the desired range (OD600≈0.5-1) and added to a 96-well titration plate, 100 microliters per well. Then, a serial dilution of equal amounts of peptides was performed (specific dilution concentrations were: 0μM, 2μM, 4μM, 6μM, 8μM, 10μM, 12μM, 14μM, 16μM, 18μM and 20μM) and incubated at 28°C for 48 hours. The lowest antimicrobial peptide concentration with no visible microbial growth under the minimum inhibitory concentration (MIC) condition was determined using the ELISA (SPARK) method. The concentration of the purified antimicrobial peptide was adjusted to the MIC level for time-kill analysis, and the same volume of peptide as the indicator bacteria was applied to a 96-well plate (at least three wells for each concentration). Then, the plate was incubated at 28°C for 2, 4, 6, 8, 10, 12 and 24 hours. Afterwards, the OD value was measured at 600nm.The inhibition test of peanut cysteine-rich peptides and control peptides was modified according to the previously described method [Guangming S., Yang Y., Yuan Q., Shi G., Wu L., Lou Z., Huo R., Wu H., Borriss R., Gao X. Bacillomycin D Produced by Bacillus amyloliquefaciens Is Involved in the Antagonistic Interaction with the Plant-Pathogenic Fungus Fusariumgraminearum. Appl. Environ. Microbiol. 2017; 83: e01075–e01117.]. Approximately 200 μL (1 mg / mL) of antimicrobial peptides were evenly mixed with 10 mL of tomato wilt fungus (Fusarium oxysporum f.sp. lycopersici) spores (10. 7 / mL) and cultured at 28°C. From 0 to 10 hours, the inhibition rate of spore count was observed and recorded every 2 hours ( Figure 4 ). To calculate the spore count inhibition rate every 2 hours, first record the spore counts of the control group and the treatment group. The control group is the number of spores that were not inhibited, and the treatment group is the number of spores that were inhibited.

[0122] The calculation formula of inhibition rate is:

[0123]

[0124] Among them, N control represents the number of spores in the control group, N treatment Represents the number of spores in the treatment group. Through this formula, the percentage reduction in the number of spores in the treatment group relative to the control group, i.e., the inhibition rate, can be calculated.

[0125] The specific steps are as follows: 1. Record the number of spores in the control group and the treatment group every 2 hours. 2. Use the above formula to calculate and obtain the inhibition rate at each recording time.

[0126] For example, if the spore count in the control group is 200 and the spore count in the treated group is 150 at a certain time point, the inhibition rate is calculated as:

[0127]

[0128] This means that at this time point, the number of spores in the treated group was reduced by 25 relative to the control group.

[0129] The experimental results showed that the MIC for tomato wilt pathogen (Fusariumoxysporumf.sp.lycopersici) was 11.6μM peanut cysteine-rich peptide and 16.8μM control peptide. In order to prepare the spore inoculum of tomato wilt pathogen (Fusariumoxysporumf.sp.lycopersici), the experimental operation was carried out according to the following steps: First, under sterile conditions, 1 mg of the strain was weighed and inoculated into 50 ml of YPD liquid medium (OD600≈0.02-0.05). The culture medium was transferred to a 250 ml Erlenmeyer flask to provide sufficient ventilation. The Erlenmeyer flask was placed in a 25°C constant temperature shaker and the shaker speed was set to 200 revolutions per minute (rpm). The culture time was 48 hours, and the OD600 value was measured regularly during the period to ensure that the spore concentration was within the required range. After the culture was completed, the culture solution was filtered using sterile gauze or filter paper, and the spore suspension was collected and stored in an appropriate preservation solution for subsequent use.

[0130] Figure 4 The inhibition time curves of peanut cysteine-rich peptides and control peptides on the growth of tomato wilt fungus (Fusarium oxysporum f. sp. lycopersici) are shown. Figure 3 The effects are similar. According to the data in the figure, peanut cysteine-rich peptides and control peptides showed significant inhibitory effects on the growth of tomato wilt fungus (Fusariumoxysporum f.sp.lycopersici) at different time points. As time went on, the antibacterial effect gradually increased, especially after 4 hours. The specific analysis results are as follows: 1. Early inhibitory effect: Within 2 hours, the antibacterial effect was relatively weak, but a certain growth inhibition effect could still be observed. Mid-term inhibitory effect: After 4 hours, the antibacterial effect was significantly enhanced, showing that peanut cysteine-rich peptides and control peptides had a strong inhibitory effect on the bacteria. Long-term inhibitory effect: At 10 hours, the antibacterial effect reached its highest point, showing that peanut cysteine-rich peptides have long-lasting and effective antibacterial activity. The antibacterial effect of peanut cysteine-rich peptides is higher than that of the control peptide ( Figure 4 ).

[0131] In general, peanut cysteine-rich peptides have a significant inhibitory effect on the growth of tomato wilt fungus (Fusarium oxysporum f. sp. lycopersici), and the inhibitory effect becomes more obvious as time goes by. This suggests that peanut cysteine-rich peptides may have potential application value in plant disease resistance.

[0132] Example 5: Analysis of the minimum inhibitory concentration (MIC) and growth inhibition time curve of peanut cysteine-rich peptide and control peptide (GenBank No. XP_015936675.1) against Rhizoctonia solani

[0133] The MIC values ​​of antimicrobial peptides were determined using the microdilution method [Saporito P., Mojsoska B., Olesen AL, Jenssen H. Antibacterial mechanisms of GN-2 derived peptides and peptoids against Escherichia coli. Biopolymers. 2019; 110: e23275; Cui H., Zhang C., Li C., Lin L. Antimicrobial mechanism of clove oil on Listeria monocytogenes. Food Control.]. First, under sterile conditions, weigh 10 mg of Rhizoctonia solani.

[0134] Mycelium, and inoculated into 50 ml of YPD liquid medium, the medium was transferred to a 250 ml Erlenmeyer flask to provide sufficient ventilation. The Erlenmeyer flask was placed in a constant temperature shaker at 28 ° C, and the shaker speed was set to 200 revolutions per minute (rpm). The culture time was 48 hours, during which the OD600 value was regularly sampled to ensure that the spore concentration was within the required range (OD600≈0.5-1) and added to a 96-well titration plate, 100 microliters per well. Then, a series of equal amounts of peptides were diluted (specific dilution concentrations: 0μM, 2μM, 4μM, 6μM, 8μM, 10μM, 12μM, 14μM, 16μM, 18μM and 20μM) and incubated at 28 ° C for 48 hours. The lowest antimicrobial peptide concentration without visible microbial growth under the minimum inhibitory concentration (MIC) condition was determined using the ELISA (SPARK) method. The concentration of purified antimicrobial peptides was adjusted to the MIC level for time-kill analysis, and the same volume of peptides as the indicated bacteria was applied to 96-well plates (at least three wells for each concentration). Then, the plates were incubated at 28°C for 2, 4, 6, 8, 10, 12, and 24 hours. Afterwards, the OD values ​​were measured at 600 nm. The inhibition assay of peanut cysteine-rich peptides and control peptides was modified as described previously [Guangming S., Yang Y., Yuan Q., Shi G., Wu L., Lou Z., Huo R., Wu H., Borriss R., Gao X. Bacillomycin D Produced by Bacillusamyloliquefaciens Is Involved in the Antagonistic Interaction with the Plant-Pathogenic Fungus Fusariumgraminearum. Appl. Environ. Microbiol. 2017; 83: e01075–e01117.]. About 200 μL (1 mg / mL) of antimicrobial peptide was evenly mixed with 10 mL of Rhizoctonia solani spores (10 7 / mL) and cultured at 28°C. From 0 to 10 hours, the inhibition rate of spore count was observed and recorded every 2 hours ( Figure 5 ). To calculate the spore count inhibition rate every 2 hours, first record the spore counts of the control group and the treatment group. The control group is the number of spores that were not inhibited, and the treatment group is the number of spores that were inhibited.

[0135] The calculation formula of inhibition rate is:

[0136]

[0137] Among them, N control represents the number of spores in the control group, N treatment Represents the number of spores in the treatment group. Through this formula, the percentage reduction in the number of spores in the treatment group relative to the control group, i.e., the inhibition rate, can be calculated.

[0138] The specific steps are as follows: 1. Record the number of spores in the control group and the treatment group every 2 hours. 2. Use the above formula to calculate and obtain the inhibition rate at each recording time.

[0139] For example, if the spore count in the control group is 200 and the spore count in the treated group is 150 at a certain time point, the inhibition rate is calculated as:

[0140]

[0141] This means that at this time point, the number of spores in the treated group was reduced by 25 relative to the control group.

[0142] The experimental results showed that the MIC for Rhizoctonia solani was 10.6 μM peanut cysteine-rich peptide and 14.5 μM control peptide. In order to prepare the spore inoculum of Rhizoctonia solani, the experimental operation was carried out according to the following steps: First, under sterile conditions, 10 mg of mycelium was weighed and inoculated into 50 ml of YPD liquid culture medium. The culture medium was transferred to a 250 ml Erlenmeyer flask to provide sufficient ventilation. The Erlenmeyer flask was placed in a constant temperature shaker at 25°C and the shaking speed was set to 200 revolutions per minute (rpm). The culture time was 48 hours, during which the OD600 value was regularly sampled to ensure that the spore concentration was within the required range (OD600=1). After the culture was completed, the culture solution was filtered using sterile gauze or filter paper, and the spore suspension was collected and stored in an appropriate preservation solution for subsequent use.

[0143] Figure 5The antibacterial time curve of peanut cysteine-rich peptide on the growth of Rhizoctonia solani is shown. According to the data in the figure, the peanut cysteine-rich peptide control peptide showed a significant inhibitory effect on the growth of Rhizoctonia solani at different time points. As time went on, the antibacterial effect gradually increased, especially after 6 hours. The specific analysis results are as follows: 1. Early inhibitory effect: Within 4 hours, the antibacterial effect was relatively weak, but a certain growth inhibition effect could still be observed. Mid-term inhibitory effect: After 6 hours, the antibacterial effect was significantly enhanced, showing that the peanut cysteine-rich peptide control peptide had a strong inhibitory effect on the pathogen. Long-term inhibitory effect: At 10 hours, the antibacterial effect reached the highest point, showing that the peanut cysteine-rich peptide has a long-lasting and effective antibacterial activity. Overall, the peanut cysteine-rich peptide has a significant inhibitory effect on the growth of Rhizoctonia solani, and the antibacterial effect is more obvious as time goes on. This suggests that the peanut cysteine-rich peptide may have potential application value in plant disease resistance. The antibacterial effect of peanut cysteine-rich peptide was higher than that of control peptide ( Figure 5 ).

[0144] Example 6: Hemolysis test

[0145] The hemolytic activity of two antimicrobial peptides (control peptide GenBank No. XP_015936675.1 and peanut cysteine-rich peptide) was evaluated according to the previously described method [Gautam A., Chaudhary K., Singh S., Joshi A., Anand P., Tuknait A., Mathur D., Varshney GC, Raghava G. Hemolytik: A database of experimentally determined hemolytic and non-hemolytic peptides. Nucleic Acids Res.]. Briefly, fresh porcine blood was centrifuged at 1500×g for 10 min at 4°C, red blood cells were collected, washed three times with pre-cooled 0-4°C 0.1M PBS buffer solution (pH=7.2, the same below), and then diluted with 0-4°C 0.1M PBS buffer solution to a 1% red blood cell suspension (V / V). Prepare equal volumes of diluted erythrocytes and antimicrobial peptide solutions (aqueous solutions), with concentrations of 1×MIC (20μM), 1.5×MIC (30μM), 2×MIC (40μM), 2.5×MIC (50μM) and 3×MIC (60μM). Take 100μL of erythrocyte suspension and mix it with 100μL of antimicrobial peptide solution of corresponding concentration and incubate at 37°C for 1 hour. After incubation, centrifuge the mixture at 4000×g for 10 minutes, and measure the absorbance of the supernatant to evaluate the hemolysis rate of erythrocytes. Using an ELISA (SPARK) plate reader, take the supernatant in a 96-well plate and measure the absorbance at 385nm. A 0.1% Triton X-100 (Sigma, model MFCD00128254) red blood cell suspension (V / V) was used as the control group ATriton, while only 1% blood cells 20nM 0.1M PBS buffer was incubated (V / V) as a negative control APBS. In addition, the hemolysis percentage of 0.1% Triton X-100 in PBS was used. The hemolytic activity percentage was calculated as follows: [(Apeptide-APBS) / (ATriton-APBS)]×100.

[0146] The final formula is used to calculate the percentage of hemolytic activity of red blood cells, that is, the degree to which the antimicrobial peptide solution causes red blood cells to rupture and release hemoglobin. The formula is as follows:

[0147]

[0148] Explain what each variable means:

[0149] A peptide : Absorbance value of the sample supernatant containing antimicrobial peptide solution. -A PBS: Absorbance value of the supernatant of the negative control group (red blood cell suspension treated with PBS buffer only). Triton : Positive control group (using 0.1mM Tritonx-100, catalog number 9036-19-5, Sigma).

[0150] Formula calculation steps:

[0151] 1. Calculate the absorbance change caused by antimicrobial peptides: A peptide -A PBS - This step indicates the amount of absorbance change caused by hemolysis (release of hemoglobin) of red blood cells caused by the antimicrobial peptide solution.

[0152] 2. Calculate the absorbance change caused by TritonX-100: A Triton -A PBS -This step shows the absorbance change caused by using 0.1mM Triton X-100.

[0153] 3. Calculate the relative hemolysis percentage caused by antimicrobial peptides: - The relative percentage of hemolysis caused by the antimicrobial peptides was obtained by comparing the absorbance change caused by the antimicrobial peptides with the absorbance change in the case of complete hemolysis.

[0154] The final result represents the hemolytic activity of the antimicrobial peptide solution on red blood cells at different concentrations, presented as a percentage. This helps to evaluate the hemolytic toxicity of the antimicrobial peptide.

[0155] Figure 6 The results of the hemolysis experiment of peanut cysteine-rich peptides and control peptides are shown. According to the data in the figure, the hemolysis rate of peanut cysteine-rich peptides and control peptides on red blood cells was measured at different concentrations. The results showed that at lower concentrations (such as 1μg / mL and 100μg / mL), the hemolysis rate was low, close to the hemolysis rate of the control group, indicating that peanut cysteine-rich peptides and control peptides had no significant destructive effect on red blood cells at these concentrations. However, when the concentration was increased to 1000μg / mL, a maximum of 2% hemolytic activity was shown. This shows that peanut cysteine-rich peptides and control peptides have low hemolytic toxicity to red blood cells at high concentrations, but are safer at low concentrations. Therefore, when peanut cysteine-rich peptides are used as antibacterial agents, their use concentrations must be carefully controlled to avoid unnecessary damage to host cells.

Claims

1. A peanut cysteine-rich peptide, which is a peanut antimicrobial peptide, characterized in that: The amino acid sequence of the antimicrobial peptide has or includes the sequence shown in SEQ ID NO.

2.

2. A gene encoding the peanut cysteine-rich peptide according to claim 1, wherein the nucleotide sequence thereof has or includes the sequence shown in SEQ ID NO.

1.

3. An antibacterial agent, characterized in that: The invention uses the peanut cysteine-rich peptide as claimed in claim 1 as an active ingredient.

4. The antibacterial agent according to claim 3, characterized in that: The antibacterial agent is a fungistatic agent and can be used for the prevention and treatment of plant fungal pathogens.

5. The antibacterial agent according to claim 3 or 4, characterized in that: The antibacterial agent inhibits one or more of the following pathogenic bacteria: wheat leaf blight fungus (Alternaria triticina), tomato wilt fungus (Fusarium oxysporum f. sp. lycopersici), sheath blight fungus (Rhizoctonia solani), potato wilt fungus (Sclerotium rolfsii), sudden wilt fungus (Pythium aphanidermatum), sunflower head rot fungus (Sclerotiniasclerotiorum), early blight fungus (Alternaria solani), tomato early blight fungus (Alternaria alternate f. sp. lycopersici), pineapple pathogen (Ceratocystis paradoxa) and late blight fungus (Phytophthora infestans).

6. Use of the peanut cysteine-rich peptide according to claim 1 in preparing an antibacterial agent.

7. The use according to claim 6, characterized in that: The antibacterial agent is a fungistatic agent and can be used for the prevention and treatment of plant fungal pathogens.

8. The use according to claim 6 or 7, characterized in that: The antibacterial agent inhibits one or more of the following pathogenic bacteria: wheat leaf blight fungus (Alternaria triticina), tomato wilt fungus (Fusarium oxysporum f. sp. lycopersici), sheath blight fungus (Rhizoctonia solani), potato wilt fungus (Sclerotium rolfsii), sudden wilt fungus (Pythium aphanidermatum), sunflower head rot fungus (Sclerotiniasclerotiorum), early blight fungus (Alternaria solani), tomato early blight fungus (Alternaria alternate f. sp. lycopersici), pineapple pathogen (Ceratocystis paradoxa) and late blight fungus (Phytophthora infestans).

Citation Information

Patent Citations

  • Garlic antimicrobial peptide AR117 and its application

    CN108017698A

  • Aegilops tauschii antimicrobial peptide AtR100 and application thereof

    CN110078806A

  • Apostichopus japonicus antibacterial peptide and application thereof

    CN116874575A

  • Peanut asparagine-rich peptide as well as application and medicine thereof

    CN118561975A

Cited By

  • Peanut endogenous peptide Hypogin derivative and application thereof

    CN119684405A

  • Peanut endogenous peptide hypogin derivatives and applications thereof

    CN119684405B